Veterinary Shock Classification: Fluid Resuscitation Endpoints and Vasopressor Escalation

Veterinary clinicians managing shock in dogs, cats, horses, camelids, and other species require a structured framework to classify shock type, set fluid resuscitation endpoints, and determine when to escalate to vasopressor therapy. This article provides a cross-species classification system for hypovolemic, distributive, cardiogenic, and obstructive shock, with practical endpoints for fluid resuscitation and criteria for vasopressor escalation based on current evidence and professional guidelines from the American Veterinary Medical Association (AVMA), American Animal Hospital Association (AAHA), American College of Veterinary Anesthesia and Analgesia (ACVAA), Merck Veterinary Manual, and World Organisation for Animal Health (WOAH).

At a Glance: Shock Classification and Initial Resuscitation Framework

Pathophysiology of Shock in Veterinary Patients

Shock represents a state of inadequate oxygen delivery to tissues, leading to cellular hypoxia, metabolic acidosis, and eventual organ dysfunction if uncorrected. The Merck Veterinary Manual describes shock as a clinical syndrome characterized by hypotension, tachycardia, altered mental status, and evidence of poor tissue perfusion. In veterinary medicine, the four main categories of shock are hypovolemic, distributive, cardiogenic, and obstructive, each requiring distinct management approaches.

The World Organisation for Animal Health (WOAH) emphasizes that animal health and welfare depend on timely recognition and appropriate management of critical conditions, including shock. Veterinary clinicians must differentiate shock types rapidly because fluid resuscitation strategies differ substantially between categories. Aggressive fluid administration in cardiogenic shock can precipitate pulmonary edema, while inadequate volume in hypovolemic shock worsens tissue hypoxia.

Fluid therapy is extensively used to treat traumatized patients as well as patients during surgery. The fluid therapy process is complex due to interpatient variability in response to therapy as well as other complicating factors such as comorbidities and general anesthesia. These complexities can result in under- or over-resuscitation. Given the complexity of the fluid management process as well as the increased capabilities in hemodynamic monitoring, closed-loop fluid management can reduce the workload of the overworked clinician while ensuring specific constraints on hemodynamic endpoints are met with higher accuracy.

Hypovolemic Shock: Recognition and Fluid Resuscitation

Hypovolemic shock results from decreased intravascular volume due to hemorrhage, dehydration, burns, or gastrointestinal losses. Clinical signs include tachycardia, weak pulses, prolonged capillary refill time, cool extremities, and altered mentation. In dogs, heart rate elevation is a consistent finding, while cats may present with bradycardia or relative bradycardia despite hypovolemia.

Fluid Resuscitation Endpoints for Hypovolemic Shock

The primary endpoint for fluid resuscitation in hypovolemic shock is restoration of adequate tissue perfusion. Clinical endpoints include normalization of heart rate, improvement in pulse quality, capillary refill time less than 2 seconds, and return of normal mentation. More objective endpoints include mean arterial pressure above 60 mmHg, urine output greater than 1 mL/kg/hour, and lactate clearance.

For burn patients, fluid resuscitation requires careful volume calculation. A randomized controlled trial comparing Ringer's lactate and isotonic bicarbonate combination therapy with Ringer's lactate alone in early fluid resuscitation of burns patients found that adding isotonic bicarbonate to Ringer's lactate did not improve perfusion but showed exploratory acid-base benefits without excess harm. The study enrolled 134 adult patients with 15 percent or greater total body surface area burns presenting within 12 hours. Median 24-hour lactate reduction was similar between Ringer's lactate and the combination therapy. Fluid requirements, urine output, acute kidney injury incidence, vasopressor use, and mortality were comparable between groups.

In acute pancreatitis, fluid resuscitation volume remains controversial. A quasi-experimental study comparing aggressive versus moderate fluid resuscitation in acute pancreatitis found that larger volumes of lactated Ringer's did not improve outcomes. The study enrolled 260 adults with first-episode acute pancreatitis assigned to aggressive (20 mL/kg bolus followed by 3 mL/kg/hour) or moderate (10 mL/kg bolus if hypovolemic, followed by 1.5 mL/kg/hour) lactated Ringer's protocols. Persistent organ failure occurred in 8.5 percent of aggressive and 6.2 percent of moderate groups. Median hospital length of stay was 6 days for aggressive and 5 days for moderate resuscitation. Despite no improvement in clinical outcomes, aggressive resuscitation yielded greater 24-hour reductions in hematocrit and blood urea nitrogen.

Colloid Use in Hypovolemic Shock

Colloid solutions such as gelatine may achieve hemodynamic stability with less fluid volume compared to crystalloids alone. A prospective, randomized, controlled, double-blind trial evaluated a balanced gelatine solution for fluid resuscitation in sepsis. The gelatine group had a more favorable fluid balance at 24 hours and less fluid overload compared to the crystalloid group. Time to hemodynamic stability was not different between groups, but the gelatine-based regimen led to better fluid balance and less fluid overload. No differences were observed in serious adverse events or mortality.

Veterinary clinicians should consider colloid use when large crystalloid volumes are required or when patients show signs of fluid overload. Colloids carry risks including allergic reactions, coagulopathy, and potential renal injury. The decision to use colloids should be individualized based on patient factors and clinical response.

Distributive Shock: Sepsis and Systemic Inflammation

Distributive shock in veterinary patients most commonly results from sepsis, systemic inflammatory response syndrome, anaphylaxis, or spinal shock. The primary hemodynamic defect is vasodilation leading to relative hypovolemia, often accompanied by myocardial depression and increased capillary permeability.

Fluid Resuscitation in Sepsis

Fluid therapy in dogs and cats with sepsis requires careful titration to avoid fluid overload while restoring perfusion. The American College of Veterinary Anesthesia and Analgesia (ACVAA) provides resources for anesthesia and critical care management, including sepsis protocols. Initial fluid resuscitation typically involves crystalloid boluses of 10-20 mL/kg in dogs and 5-10 mL/kg in cats, with reassessment after each bolus.

Endpoints for fluid resuscitation in distributive shock include mean arterial pressure above 65 mmHg, lactate clearance, central venous oxygen saturation above 70 percent, and urine output above 1 mL/kg/hour. No single endpoint is sufficient, clinicians should use a combination of clinical and hemodynamic parameters.

The GENIUS trial demonstrated that a balanced gelatine solution for fluid resuscitation in sepsis achieved hemodynamic stability after 4.7 hours in the gelatine group compared to 5.8 hours in the crystalloid group. The gelatine group had a more favorable fluid balance at 24 hours and less fluid overload. These findings suggest that colloid use may reduce total fluid volume requirements in septic patients.

Vasopressor Escalation in Distributive Shock

Vasopressor therapy should be considered when hypotension persists despite adequate fluid resuscitation. In distributive shock, vasopressors are often required earlier than in hypovolemic shock because vasodilation is a primary pathophysiologic mechanism. The decision to start vasopressors should be based on persistent hypotension after 30-40 mL/kg crystalloid administration in dogs or 20-30 mL/kg in cats, or earlier if fluid overload is a concern.

Common vasopressors used in veterinary medicine include norepinephrine, dopamine, vasopressin, and dobutamine. Norepinephrine is often the first-line vasopressor for distributive shock due to its potent alpha-adrenergic effects with minimal beta-adrenergic stimulation. Vasopressin may be added as a second-line agent or in patients with refractory hypotension.

Veterinary clinicians should monitor for vasopressor complications including arrhythmias, tissue ischemia, and increased myocardial oxygen demand. Vasopressor doses should be titrated to the lowest effective dose to achieve target blood pressure.

Cardiogenic Shock: Recognition and Management

Cardiogenic shock results from pump failure due to myocardial dysfunction, valvular disease, arrhythmias, or pericardial disease. Clinical signs include tachycardia or bradycardia, weak pulses, pulmonary edema, jugular distension, and hepatomegaly. Unlike hypovolemic shock, cardiogenic shock requires cautious fluid administration to avoid worsening pulmonary edema.

Fluid Resuscitation Endpoints in Cardiogenic Shock

Fluid resuscitation in cardiogenic shock should be conservative. Initial crystalloid boluses of 5-10 mL/kg in dogs and 2-5 mL/kg in cats are appropriate, with careful monitoring for signs of fluid overload including increased respiratory rate, crackles on auscultation, or worsening jugular distension. Endpoints include improvement in perfusion without worsening respiratory status.

More objective endpoints include central venous pressure monitoring, with target values typically between 5-10 cmH2O. Central venous pressure is a poor predictor of fluid responsiveness and should be interpreted in context with other clinical parameters.

Vasopressor and Inotrope Use in Cardiogenic Shock

Vasopressor and inotrope therapy is often required in cardiogenic shock to support cardiac output and tissue perfusion. Dobutamine is a common inotrope used for its beta-adrenergic effects, increasing contractility and heart rate. Norepinephrine may be added for vasopressor support if hypotension persists.

Veterinary clinicians should monitor for arrhythmias, increased myocardial oxygen demand, and worsening of underlying cardiac disease. The goal is to achieve adequate perfusion while minimizing myocardial stress.

Obstructive Shock: Mechanical Causes

Obstructive shock results from mechanical obstruction to blood flow, most commonly from pericardial effusion, tension pneumothorax, pulmonary thromboembolism, or gastric dilatation-volvulus. Treatment focuses on relieving the obstruction instead of fluid resuscitation.

Fluid Resuscitation in Obstructive Shock

Fluid resuscitation in obstructive shock is variable and depends on the underlying cause. In pericardial effusion with cardiac tamponade, fluid administration may temporarily improve cardiac output by increasing preload, but definitive treatment requires pericardiocentesis. In tension pneumothorax, thoracocentesis is the priority. In gastric dilatation-volvulus, decompression and surgical correction are essential.

Vasopressor therapy may be needed after the obstruction is relieved if hypotension persists. Vasopressors are not first-line therapy for obstructive shock.

Practical Implementation: Step-by-Step Assessment and Resuscitation

Step 1: Initial Assessment and Shock Classification

The first step in managing a shock patient is rapid assessment and classification. Obtain a brief history, perform a physical examination, and assess vital signs including heart rate, respiratory rate, mucous membrane color, capillary refill time, pulse quality, and mentation. Measure blood pressure if possible. Classify shock type based on clinical findings.

Step 2: Establish Vascular Access

Place one or two large-bore intravenous catheters. In hypovolemic shock, intraosseous access may be used if intravenous access is not possible. In cardiogenic shock, central venous access may be preferred for monitoring central venous pressure.

Step 3: Initiate Fluid Resuscitation

Start fluid resuscitation based on shock type. For hypovolemic and distributive shock, administer crystalloid boluses of 10-20 mL/kg in dogs and 5-10 mL/kg in cats over 10-15 minutes. Reassess after each bolus. For cardiogenic shock, use smaller boluses of 5-10 mL/kg in dogs and 2-5 mL/kg in cats. For obstructive shock, treat the underlying cause first.

Step 4: Monitor Resuscitation Endpoints

Monitor clinical endpoints including heart rate, pulse quality, capillary refill time, mentation, and blood pressure. Measure lactate, central venous oxygen saturation, and urine output if possible. Adjust fluid therapy based on response.

Step 5: Consider Vasopressor Escalation

If hypotension persists after adequate fluid resuscitation, consider vasopressor therapy. In distributive shock, vasopressors may be started earlier. In cardiogenic shock, inotropes may be preferred. In hypovolemic shock, vasopressors are rarely needed if volume resuscitation is adequate.

Step 6: Reassess and Adjust

Continuously reassess the patient and adjust therapy based on response. Fluid overload is a significant risk, especially in patients with cardiac disease, renal disease, or sepsis. Monitor for signs of fluid overload including increased respiratory rate, crackles, and peripheral edema.

Records and Measurements

Accurate record-keeping is essential for managing shock patients. Document the following parameters:

• Initial vital signs and shock classification
• Fluid type, volume, and rate of administration
• Patient response to each fluid bolus
• Blood pressure measurements
• Lactate levels
• Urine output
• Vasopressor type, dose, and duration
• Complications or adverse events

Use a standardized flow sheet to track trends over time. Record the time of each intervention and the patient's response.

Common Failure Patterns

Under-Resuscitation

Under-resuscitation occurs when inadequate fluid volume is administered, leading to persistent tissue hypoxia and organ dysfunction. This is most common in hypovolemic and distributive shock when clinicians underestimate fluid requirements. Signs include persistent tachycardia, hypotension, prolonged capillary refill time, and elevated lactate.

Over-Resuscitation

Over-resuscitation occurs when excessive fluid volume is administered, leading to fluid overload, pulmonary edema, and tissue edema. This is most common in cardiogenic shock and distributive shock with increased capillary permeability. Signs include increased respiratory rate, crackles, peripheral edema, and worsening oxygenation.

Delayed Vasopressor Escalation

Delayed vasopressor escalation occurs when clinicians continue fluid resuscitation despite persistent hypotension and signs of fluid overload. This is most common in distributive shock where vasodilation is the primary problem. Early vasopressor use may reduce total fluid requirements and improve outcomes.

Failure to Identify Obstructive Shock

Obstructive shock is often missed because clinical signs may mimic other shock types. Pericardial effusion with cardiac tamponade may present with muffled heart sounds, jugular distension, and pulsus paradoxus. Tension pneumothorax presents with absent lung sounds, tracheal deviation, and respiratory distress. Gastric dilatation-volvulus presents with abdominal distension and retching.

Limitations and Safety Context

Limitations of Current Evidence

Much of the evidence for fluid resuscitation and vasopressor use in veterinary medicine is extrapolated from human studies. Veterinary-specific studies are limited, and species differences in cardiovascular physiology may affect response to therapy. Cats have different cardiovascular responses to fluid administration compared to dogs, and horses have unique fluid requirements.

The closed-loop fluid management systems described in the literature are not yet widely available in veterinary practice. Current fluid management relies on clinician judgment and intermittent monitoring.

Safety Considerations

Fluid resuscitation carries risks including fluid overload, electrolyte disturbances, and coagulopathy. Colloid solutions carry additional risks including allergic reactions and potential renal injury. Vasopressor therapy carries risks including arrhythmias, tissue ischemia, and increased myocardial oxygen demand.

Veterinary clinicians should monitor for complications and adjust therapy accordingly. Patients with cardiac disease, renal disease, or sepsis are at higher risk for fluid overload and require more cautious fluid administration.

Professional Escalation Criteria

Veterinary clinicians should escalate care to a specialist or referral facility when:

• Shock is refractory to initial fluid resuscitation and vasopressor therapy
• Advanced hemodynamic monitoring is needed
• Underlying cause requires specialized intervention such as pericardiocentesis, thoracocentesis, or surgery
• Patient develops complications such as fluid overload, arrhythmias, or organ dysfunction
• Diagnosis is uncertain or shock type is unclear

The American Veterinary Medical Association (AVMA) provides resources for animal health and welfare, including guidelines for referral and emergency care. The American Animal Hospital Association (AAHA) offers accreditation standards and resources for veterinary practices.

Dynamic Fluid Responsiveness Assessment: Passive Leg Raise and End-Expiratory Occlusion Test in Veterinary Patients

Accurate assessment of fluid responsiveness is a critical skill in veterinary shock management, as it directly determines whether additional fluid boluses will improve cardiac output or contribute to fluid overload. Traditional static measures such as central venous pressure, heart rate, and blood pressure have limited predictive value for fluid responsiveness in veterinary patients. Dynamic assessment techniques that exploit heart-lung interactions provide more reliable guidance for fluid resuscitation decisions. This section describes two practical dynamic fluid responsiveness tests that can be performed in clinical veterinary settings: the passive leg raise (PLR) and the end-expiratory occlusion test (EEOT). These tests are applicable across species and shock types, with specific modifications for dogs, cats, horses, and camelids.

Physiological Basis of Dynamic Fluid Responsiveness Testing

Dynamic fluid responsiveness tests rely on the principle that a transient increase in venous return will produce a measurable increase in stroke volume or cardiac output only if both ventricles are operating on the ascending portion of the Frank-Starling curve. Patients who are fluid responsive demonstrate a significant increase in stroke volume when preload is transiently increased, while non-responsive patients show minimal or no change. The Merck Veterinary Manual describes the Frank-Starling relationship as fundamental to understanding cardiac function and fluid responsiveness in veterinary patients.

The PLR test works by transferring approximately 300 mL of blood from the lower extremities and splanchnic circulation to the central circulation in a 70 kg human, with proportionally smaller volumes in veterinary patients. This autotransfusion effect is rapidly reversible when the patient returns to the original position, making PLR a safe and repeatable test. The EEOT works by interrupting positive pressure ventilation for 15-30 seconds, which eliminates the cyclic decrease in venous return caused by inspiratory positive pressure, thereby increasing preload.

The American College of Veterinary Anesthesia and Analgesia (ACVAA) provides resources on hemodynamic monitoring that support the use of dynamic assessment techniques in veterinary critical care. These tests are particularly valuable in distributive shock where vasodilation and capillary leak make static measures unreliable, and in cardiogenic shock where fluid administration carries significant risk of pulmonary edema.

Passive Leg Raise Test: Procedure and Interpretation

The PLR test is performed by moving the patient from a semi-recumbent or horizontal position to a position where the hindlimbs are elevated approximately 45 degrees above the level of the heart. In dogs and cats, this can be achieved by lifting the hindquarters while keeping the thorax and head in a horizontal or slightly elevated position. In horses, the test is more challenging due to size constraints but can be performed by elevating the hindlimbs using a hoist or by tilting the entire patient on a tilt table. In camelids, the test is performed with the patient in sternal recumbency and the hindlimbs elevated.

Step-by-Step PLR Procedure for Dogs and Cats

1. Position the patient in lateral or sternal recumbency with the thorax and head at a 0 to 20 degree angle relative to horizontal.
2. Measure baseline cardiac output, stroke volume, or a surrogate such as pulse pressure variation, velocity-time integral on echocardiography, or end-tidal carbon dioxide.
3. Elevate the hindlimbs to approximately 45 degrees above the level of the heart for 30 to 90 seconds.
4. Measure the same hemodynamic parameter during the elevation period.
5. Return the patient to the original position and confirm return to baseline values.
6. Calculate the percentage change in the measured parameter.

A positive PLR test, indicating fluid responsiveness, is defined as a 10 to 15 percent increase in stroke volume or cardiac output during hindlimb elevation. In clinical practice where direct cardiac output measurement is unavailable, surrogate measures can be used. An increase in pulse pressure of more than 9 percent during PLR has been shown to predict fluid responsiveness in dogs. An increase in end-tidal carbon dioxide of more than 2 mmHg during PLR may also indicate fluid responsiveness, as increased cardiac output delivers more carbon dioxide to the lungs.

Limitations and Contraindications for PLR

The PLR test has several limitations in veterinary practice. Patients with increased intra-abdominal pressure from gastric dilatation-volvulus, ascites, or pregnancy may have reduced venous return from the lower extremities, leading to false negative results. Patients with intracranial hypertension should not undergo PLR because the transient increase in central venous pressure may further increase intracranial pressure. The test is unreliable in patients with severe peripheral vasodilation because the autotransfused blood may pool in the splanchnic circulation instead of reaching the heart.

In cats, the PLR test is more difficult to interpret due to their small size and the relatively small volume of blood transferred. Some clinicians recommend using a modified PLR in cats where the entire body is tilted head-down at a 15 to 20 degree angle instead of elevating only the hindlimbs. This position should be maintained for no more than 30 seconds to minimize the risk of cerebral edema.

End-Expiratory Occlusion Test: Procedure and Interpretation

The EEOT is performed by interrupting mechanical ventilation at end-expiration for 15 to 30 seconds. During this period, the positive pressure that normally impedes venous return during inspiration is eliminated, allowing increased preload to the right heart. The test is only applicable to patients receiving positive pressure ventilation, which limits its use to anesthetized or critically ill patients on mechanical ventilators.

Step-by-Step EEOT Procedure

1. Confirm that the patient is receiving controlled mechanical ventilation with a consistent tidal volume and respiratory rate.
2. Measure baseline cardiac output, stroke volume, or a surrogate parameter.
3. Activate the end-expiratory hold function on the ventilator for 15 seconds in small animals and up to 30 seconds in horses and large camelids.
4. Measure the same hemodynamic parameter during the last 5 seconds of the occlusion period.
5. Resume mechanical ventilation and confirm return to baseline values.
6. Calculate the percentage change in the measured parameter.

A positive EEOT is defined as a 5 percent or greater increase in cardiac output or stroke volume during the occlusion period. The lower threshold compared to PLR reflects the smaller preload increase achieved with EEOT. In dogs, an increase in pulse pressure of more than 5 percent during EEOT has been shown to predict fluid responsiveness with reasonable accuracy.

Limitations and Contraindications for EEOT

The EEOT is only applicable to patients receiving controlled mechanical ventilation. Patients breathing spontaneously or on pressure support ventilation cannot undergo this test because they will trigger breaths during the occlusion period. The test is unreliable in patients with high intrinsic positive end-expiratory pressure because the occlusion may not effectively eliminate the inspiratory impedance to venous return.

Patients with severe hypoxemia or hemodynamic instability may not tolerate even a 15-second interruption of ventilation. In these cases, the test should be performed with caution and terminated immediately if oxygen saturation drops below 90 percent or if the patient shows signs of distress. The EEOT should not be performed in patients with known or suspected pulmonary embolism because the reduction in venous return during the test may worsen hemodynamic compromise.

Practical Decision Framework for Dynamic Testing

The following decision framework integrates dynamic fluid responsiveness testing into the shock resuscitation algorithm described in the existing article. This framework is designed for use after initial shock classification and before proceeding to large-volume fluid resuscitation or vasopressor escalation.

Step 1: Determine Test Eligibility

Assess whether the patient is a candidate for dynamic fluid responsiveness testing. Patients with hypovolemic shock from obvious hemorrhage or severe dehydration may not require testing because they are likely fluid responsive and delaying resuscitation could be harmful. Patients with distributive shock, cardiogenic shock, or mixed shock types benefit most from dynamic testing because the risk of fluid overload is higher and the benefit of additional fluid is less certain.

Eligibility criteria for PLR testing include:

• Hemodynamic stability sufficient to tolerate position change
• No contraindications such as intracranial hypertension or severe intra-abdominal hypertension
• Ability to measure a hemodynamic parameter that reflects cardiac output

Eligibility criteria for EEOT testing include:

• Controlled mechanical ventilation with consistent tidal volume
• Hemodynamic stability sufficient to tolerate 15-30 second ventilation interruption
• No severe hypoxemia or known pulmonary embolism

Step 2: Perform the Test

Select the appropriate test based on patient status and available monitoring. In spontaneously breathing patients, PLR is the only option. In mechanically ventilated patients, EEOT may be preferred because it does not require patient repositioning and is less affected by intra-abdominal pressure.

Perform the test according to the step-by-step procedures described above. Record baseline and test values for the chosen hemodynamic parameter. Document the test result as positive or negative based on the established thresholds.

Step 3: Interpret the Result and Guide Therapy

A positive test indicates that the patient is likely fluid responsive and will benefit from an additional fluid bolus. Administer a crystalloid bolus of 10-20 mL/kg in dogs or 5-10 mL/kg in cats, then reassess. Repeat the dynamic test after the bolus to determine if the patient remains fluid responsive.

A negative test indicates that the patient is unlikely to benefit from additional fluid and may be at risk for fluid overload. Consider vasopressor escalation if hypotension persists, or inotropic support if cardiogenic shock is suspected. Do not administer additional fluid boluses based on the negative test result.

In patients with equivocal results where the change in the measured parameter falls between 5 and 10 percent for PLR or between 3 and 5 percent for EEOT, consider repeating the test after a small fluid challenge of 5 mL/kg crystalloid. If the repeat test remains equivocal, the patient is likely non-responsive and vasopressor escalation should be considered.

Step 4: Integrate with Other Clinical Parameters

Dynamic fluid responsiveness tests should not be used in isolation. Integrate the test result with other clinical parameters including heart rate, blood pressure, lactate, urine output, and signs of fluid overload. A positive test in a patient with severe hypotension and elevated lactate supports aggressive fluid resuscitation. A positive test in a patient with normal blood pressure and declining lactate may indicate that fluid resuscitation is adequate and vasopressor escalation is not needed.

In patients with distributive shock from sepsis, dynamic testing is particularly valuable because capillary leak makes static measures unreliable. The Frontiers in Veterinary Science review on fluid therapy in dogs and cats with sepsis emphasizes that individualized fluid management based on dynamic assessment may reduce the risk of fluid overload while ensuring adequate resuscitation.

Record System for Dynamic Fluid Responsiveness Testing

Accurate documentation of dynamic fluid responsiveness testing is essential for tracking patient response and guiding ongoing resuscitation. The following record system is designed for integration into existing patient flow sheets.

Test Documentation Template

Interpretation and Action Record

Serial Testing Log

Record each dynamic test in sequence to track changes in fluid responsiveness over time. As resuscitation progresses, patients typically transition from fluid responsive to non-responsive. Document the cumulative fluid volume administered at the time of each test and the corresponding test result.

Common Failure Patterns in Dynamic Testing

False Positive Results

False positive PLR results occur when the increase in measured parameter during hindlimb elevation is due to factors other than increased preload. In patients with severe peripheral vasodilation, the autotransfused blood may pool in the splanchnic circulation, causing a transient increase in measured parameter that does not reflect true fluid responsiveness. In patients with arrhythmias, the variation in stroke volume from beat to beat may be misinterpreted as a response to PLR.

False positive EEOT results occur when the patient triggers a breath during the occlusion period, causing a Valsalva maneuver that increases intrathoracic pressure and falsely elevates cardiac output. This can be prevented by ensuring adequate sedation or neuromuscular blockade during the test.

False Negative Results

False negative PLR results occur when the hindlimbs are not elevated sufficiently to achieve adequate venous return, or when the patient has increased intra-abdominal pressure that prevents blood from moving from the splanchnic circulation to the heart. In obese patients, the volume of blood transferred from the lower extremities may be insufficient to produce a measurable change.

False negative EEOT results occur when the occlusion period is too short to allow adequate preload increase, or when the patient has high intrinsic positive end-expiratory pressure that is not eliminated by the end-expiratory hold. In patients with severe right ventricular dysfunction, the increase in preload may not translate into increased stroke volume even if the left ventricle is fluid responsive.

Technical Errors

Technical errors in PLR include measuring the hemodynamic parameter too early or too late during the elevation period. The peak effect of PLR occurs between 30 and 60 seconds after elevation, and measurements taken before or after this window may miss the response. In cats, the peak effect occurs earlier, typically between 15 and 30 seconds.

Technical errors in EEOT include failing to confirm that the ventilator is in controlled mode, or using an occlusion period that is too short. The minimum occlusion period for reliable results is 15 seconds in small animals and 20 seconds in large animals. Shorter periods may not allow sufficient time for the preload increase to affect cardiac output.

Welfare and Safety Context

Dynamic fluid responsiveness testing is generally safe when performed correctly, but carries specific risks that must be managed. The World Organisation for Animal Health (WOAH) emphasizes that animal health and welfare depend on minimizing stress and discomfort during diagnostic and therapeutic procedures.

Patient Positioning and Stress

The PLR test requires patient repositioning, which can cause stress in anxious or painful patients. In dogs and cats, gentle handling and minimal restraint should be used. In horses, the test should be performed in a quiet environment with adequate personnel to ensure safety. In camelids, the test should be performed with the patient in sternal recumbency to minimize stress and risk of injury.

Patients with fractures, spinal injuries, or severe abdominal distension should not undergo PLR because repositioning may cause pain or worsen the underlying condition. In these patients, EEOT should be used if mechanical ventilation is available, or alternative assessment methods such as passive leg raising without full elevation should be considered.

Ventilation Interruption Risks

The EEOT requires interrupting mechanical ventilation, which can cause hypoxemia in patients with marginal oxygenation. Patients should be pre-oxygenated with 100 percent oxygen for 2-3 minutes before the test. The occlusion period should be limited to 15 seconds in patients with oxygen saturation below 95 percent or in those with known pulmonary pathology.

Patients with high intracranial pressure should not undergo EEOT because the interruption of ventilation may cause hypercapnia, which increases cerebral blood flow and intracranial pressure. In these patients, PLR should be used instead, with careful monitoring for changes in neurologic status.

Monitoring During Testing

Continuous monitoring of heart rate, blood pressure, oxygen saturation, and end-tidal carbon dioxide is essential during dynamic testing. The test should be terminated immediately if the patient shows signs of distress, oxygen saturation drops below 90 percent, or blood pressure decreases by more than 10 percent from baseline.

After the test, the patient should be returned to the original position and monitored for 2-3 minutes to confirm return to baseline hemodynamic parameters. Any persistent changes should be investigated and addressed.

Professional Escalation Criteria for Dynamic Testing

Veterinary clinicians should seek consultation or refer to a specialist when:

• Dynamic testing results are consistently equivocal despite repeated attempts
• The patient shows signs of fluid overload during or after testing
• The patient requires advanced hemodynamic monitoring such as echocardiography or pulse contour analysis to interpret test results
• The patient has complex comorbidities such as pulmonary hypertension, right ventricular failure, or severe valvular disease that complicate test interpretation
• The clinician is unfamiliar with the test procedure or interpretation

The American Animal Hospital Association (AAHA) provides accreditation standards and resources for veterinary practices that include recommendations for hemodynamic monitoring and fluid management. The American Veterinary Medical Association (AVMA) offers guidelines for referral and emergency care that can help clinicians determine when specialist input is needed.

Integration with Existing Resuscitation Protocol

Dynamic fluid responsiveness testing should be integrated into the existing shock resuscitation protocol at the point where the clinician is deciding whether to administer additional fluid boluses or escalate to vasopressor therapy. The following algorithm summarizes the integration:

1. Classify shock type using the framework described in the existing article.
2. Administer initial fluid bolus based on shock type and patient size.
3. Reassess clinical endpoints including heart rate, blood pressure, lactate, and urine output.
4. If endpoints are not achieved and the patient is stable, perform dynamic fluid responsiveness testing.
5. If the test is positive, administer an additional fluid bolus and repeat the test.
6. If the test is negative, consider vasopressor escalation or inotropic support.
7. If the test is equivocal, administer a small test bolus and repeat the test.
8. Continue this cycle until clinical endpoints are achieved or the patient becomes non-responsive.

This approach reduces the risk of both under-resuscitation and over-resuscitation by ensuring that fluid is administered only when it is likely to improve cardiac output. The Frontiers in Veterinary Science review on closed-loop control for fluid resuscitation notes that dynamic assessment techniques can improve the accuracy of fluid management and reduce clinician workload when integrated into structured protocols.

Frequently Asked Questions

What are the four types of shock in veterinary medicine?

The four types of shock are hypovolemic, distributive, cardiogenic, and obstructive. Hypovolemic shock results from decreased intravascular volume due to hemorrhage, dehydration, or burns. Distributive shock results from vasodilation due to sepsis, systemic inflammation, or anaphylaxis. Cardiogenic shock results from pump failure due to myocardial dysfunction or valvular disease. Obstructive shock results from mechanical obstruction to blood flow due to pericardial effusion, tension pneumothorax, or gastric dilatation-volvulus.

How do I determine if a shock patient is fluid responsive?

Fluid responsiveness is assessed by administering a fluid bolus and monitoring for improvement in clinical endpoints including heart rate, pulse quality, capillary refill time, mentation, and blood pressure. A patient who shows improvement after a fluid bolus is likely fluid responsive. Patients who do not improve or who develop signs of fluid overload may require vasopressor therapy or alternative interventions.

When should I start vasopressors in a shock patient?

Vasopressors should be considered when hypotension persists despite adequate fluid resuscitation. In distributive shock, vasopressors may be started earlier because vasodilation is a primary pathophysiologic mechanism. In cardiogenic shock, inotropes may be preferred. In hypovolemic shock, vasopressors are rarely needed if volume resuscitation is adequate. The decision to start vasopressors should be based on persistent hypotension after 30-40 mL/kg crystalloid administration in dogs or 20-30 mL/kg in cats, or earlier if fluid overload is a concern.

What are the endpoints for fluid resuscitation in shock?

Endpoints for fluid resuscitation include normalization of heart rate, improvement in pulse quality, capillary refill time less than 2 seconds, return of normal mentation, mean arterial pressure above 60-65 mmHg, urine output greater than 1 mL/kg/hour, and lactate clearance. No single endpoint is sufficient, clinicians should use a combination of clinical and hemodynamic parameters.

Can I use colloid solutions for fluid resuscitation in veterinary patients?

Colloid solutions such as gelatine may be used for fluid resuscitation, particularly when large crystalloid volumes are required or when patients show signs of fluid overload. Evidence from human studies suggests that gelatine-based regimens may achieve hemodynamic stability with less fluid volume and better fluid balance compared to crystalloids alone. Colloids carry risks including allergic reactions, coagulopathy, and potential renal injury. The decision to use colloids should be individualized based on patient factors and clinical response.

How do I manage fluid resuscitation in cats compared to dogs?

Cats have different cardiovascular responses to fluid administration compared to dogs. Cats may present with bradycardia or relative bradycardia despite hypovolemia, and they are more susceptible to fluid overload. Initial fluid boluses in cats should be smaller, typically 5-10 mL/kg for hypovolemic and distributive shock and 2-5 mL/kg for cardiogenic shock. Cats require more cautious fluid administration and closer monitoring for signs of fluid overload.

What is the role of lactate monitoring in shock management?

Lactate monitoring is used to assess tissue perfusion and response to therapy. Elevated lactate indicates tissue hypoxia and anaerobic metabolism. Lactate clearance, or the decrease in lactate over time, is a marker of resuscitation success. Serial lactate measurements can guide fluid therapy and vasopressor escalation. Lactate levels can be affected by other factors including liver disease, seizures, and certain medications.

When should I refer a shock patient to a specialist or referral facility?

Referral to a specialist or referral facility is indicated when shock is refractory to initial fluid resuscitation and vasopressor therapy, advanced hemodynamic monitoring is needed, the underlying cause requires specialized intervention such as pericardiocentesis or surgery, the patient develops complications such as fluid overload or organ dysfunction, or the diagnosis is uncertain. The American Veterinary Medical Association (AVMA) and American Animal Hospital Association (AAHA) provide resources for referral and emergency care.

Related Veterinary Guides

• Veterinary Science
• Livestock Nutrition And Feed Management A Cross Species Decision Framework
• Diagnostic Cytology Fluid Analysis
• Blood Gas Analysis And Acid Base Interpretation In Veterinary Patients
• Veterinary Clinical Methods Procedures Surgical Interventions

References and Further Reading

• www.avma.org
• www.aaha.org
• www.acvaa.org
• Merck Veterinary Manual. Merck Veterinary Manual.
• Animal Health and Welfare. World Organisation for Animal Health.
• Closed-Loop Control for Fluid Resuscitation: Recent Advances and Future Challenges. Frontiers in Veterinary Science, 2021.
• Approach to the critically ill camelid.. The Veterinary clinics of North America. Food animal practice, 2009.
• Efficacy and Safety of a Balanced Gelatine Solution for Fluid Resuscitation in Sepsis: A Prospective, Randomised, Controlled, Double-Blind Trial-GENIUS Trial. Journal of Clinical Medicine, 2025.
• Comparison of effect of Ringer's lactate and isotonic bicarbonate combination therapy with Ringer's lactate alone in early fluid resuscitation of burns patients - A randomised controlled trial.. Burns, 2025.
• Clinical outcomes between aggressive versus moderate fluid resuscitation in the management of acute pancreatitis: a quasi-experimental study. Journal of Rehman Medical Institute, 2025.
• Fluid Therapy in Dogs and Cats With Sepsis. Frontiers in Veterinary Science, 2021.

This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.